Integral Health Asset Management’s Charles River Laboratories CRL Stock Holding History

Integral Health Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,000	Closed	-$8.98M	–	96
2025 Q4	$8.98M	Sell	45,000 -15,000	-25%	-$2.72M	0.45%	61
2025 Q3	$9.39M	Sell	60,000 -55,000	-48%	-$8.74M	0.64%	55
2025 Q2	$17.4M	Buy	+115,000	New	+$15.3M	1.6%	21
2024 Q2	–	Sell	-65,000	Closed	-$17.6M	–	84
2024 Q1	$17.6M	Hold	65,000	–	–	1.63%	22
2023 Q4	$15.4M	Buy	+65,000	New	+$12.8M	2.09%	14
2021 Q2	–	Sell	-35,000	Closed	-$10.1M	–	77
2021 Q1	$10.1M	Sell	35,000 -18,000	-34%	-$5M	2.9%	9
2020 Q4	$13.2M	Buy	53,000 +20,000	+61%	+$4.76M	3.94%	6
2020 Q3	$7.47M	Sell	33,000 -22,000	-40%	-$4.57M	2.29%	14
2020 Q2	$9.59M	Buy	+55,000	New	+$8.78M	2.87%	6

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Integral Health Asset Management's CRL Position: Q1 2026 in Review

Integral Health Asset Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 45,000 shares — an estimated $8.98M sold.

Integral Health Asset Management first reported a position in CRL in Q2 2020 and held it in 9 quarters. The position peaked at $17.6M in Q1 2024. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Integral Health Asset Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
Integral Health Asset Management sold 45,000 Charles River Laboratories shares in Q1 2026, an estimated $8.98M.
Integral Health Asset Management first reported a position in Charles River Laboratories in Q2 2020 and held it in 9 quarters.
Integral Health Asset Management's Charles River Laboratories position peaked at $17.6M in Q1 2024.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.